Karakasis P, Patoulias D, Pamporis K, Stachteas P, et al. Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials. Metabolism 2023 Oct 16:155710. doi: 10.1016/j.metabol.2023.155710.
PMID: 37852529